Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 6 |
GO:0110165 | cellular anatomical entity | 1 | 6 |
Related structures:
AlphaFold database: E9AL90
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 139 | 143 | PF00656 | 0.592 |
CLV_C14_Caspase3-7 | 152 | 156 | PF00656 | 0.510 |
CLV_NRD_NRD_1 | 101 | 103 | PF00675 | 0.640 |
CLV_NRD_NRD_1 | 118 | 120 | PF00675 | 0.681 |
CLV_NRD_NRD_1 | 12 | 14 | PF00675 | 0.649 |
CLV_NRD_NRD_1 | 287 | 289 | PF00675 | 0.461 |
CLV_NRD_NRD_1 | 68 | 70 | PF00675 | 0.765 |
CLV_PCSK_FUR_1 | 284 | 288 | PF00082 | 0.355 |
CLV_PCSK_FUR_1 | 64 | 68 | PF00082 | 0.749 |
CLV_PCSK_KEX2_1 | 100 | 102 | PF00082 | 0.646 |
CLV_PCSK_KEX2_1 | 117 | 119 | PF00082 | 0.653 |
CLV_PCSK_KEX2_1 | 12 | 14 | PF00082 | 0.649 |
CLV_PCSK_KEX2_1 | 286 | 288 | PF00082 | 0.454 |
CLV_PCSK_KEX2_1 | 66 | 68 | PF00082 | 0.752 |
CLV_PCSK_PC7_1 | 64 | 70 | PF00082 | 0.711 |
CLV_PCSK_SKI1_1 | 250 | 254 | PF00082 | 0.480 |
DEG_APCC_DBOX_1 | 249 | 257 | PF00400 | 0.340 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.464 |
DOC_MAPK_HePTP_8 | 243 | 255 | PF00069 | 0.430 |
DOC_MAPK_JIP1_4 | 250 | 256 | PF00069 | 0.296 |
DOC_MAPK_MEF2A_6 | 171 | 180 | PF00069 | 0.526 |
DOC_MAPK_MEF2A_6 | 246 | 255 | PF00069 | 0.421 |
DOC_PP4_FxxP_1 | 38 | 41 | PF00568 | 0.476 |
DOC_USP7_MATH_1 | 140 | 144 | PF00917 | 0.507 |
DOC_USP7_MATH_1 | 146 | 150 | PF00917 | 0.588 |
DOC_USP7_MATH_1 | 80 | 84 | PF00917 | 0.435 |
LIG_14-3-3_CanoR_1 | 171 | 178 | PF00244 | 0.390 |
LIG_Actin_WH2_2 | 176 | 191 | PF00022 | 0.465 |
LIG_BRCT_BRCA1_1 | 176 | 180 | PF00533 | 0.387 |
LIG_FHA_1 | 171 | 177 | PF00498 | 0.480 |
LIG_FHA_1 | 183 | 189 | PF00498 | 0.432 |
LIG_FHA_2 | 137 | 143 | PF00498 | 0.523 |
LIG_FHA_2 | 45 | 51 | PF00498 | 0.509 |
LIG_LIR_Apic_2 | 207 | 212 | PF02991 | 0.506 |
LIG_LIR_Gen_1 | 260 | 270 | PF02991 | 0.214 |
LIG_LIR_Gen_1 | 5 | 16 | PF02991 | 0.477 |
LIG_LIR_Gen_1 | 50 | 60 | PF02991 | 0.505 |
LIG_LIR_Nem_3 | 177 | 183 | PF02991 | 0.425 |
LIG_LIR_Nem_3 | 5 | 11 | PF02991 | 0.414 |
LIG_LIR_Nem_3 | 50 | 56 | PF02991 | 0.500 |
LIG_NRBOX | 252 | 258 | PF00104 | 0.342 |
LIG_SH2_CRK | 209 | 213 | PF00017 | 0.504 |
LIG_SH2_CRK | 53 | 57 | PF00017 | 0.496 |
LIG_SH2_CRK | 8 | 12 | PF00017 | 0.411 |
LIG_SH2_GRB2like | 209 | 212 | PF00017 | 0.455 |
LIG_SH2_NCK_1 | 53 | 57 | PF00017 | 0.496 |
LIG_SH2_SRC | 209 | 212 | PF00017 | 0.455 |
LIG_SH2_STAT3 | 236 | 239 | PF00017 | 0.369 |
LIG_SH2_STAT5 | 231 | 234 | PF00017 | 0.458 |
LIG_SH3_3 | 245 | 251 | PF00018 | 0.435 |
LIG_TRAF2_1 | 49 | 52 | PF00917 | 0.517 |
MOD_CK1_1 | 144 | 150 | PF00069 | 0.815 |
MOD_CK1_1 | 174 | 180 | PF00069 | 0.488 |
MOD_CK2_1 | 44 | 50 | PF00069 | 0.642 |
MOD_Cter_Amidation | 98 | 101 | PF01082 | 0.542 |
MOD_GlcNHglycan | 144 | 147 | PF01048 | 0.737 |
MOD_GlcNHglycan | 148 | 151 | PF01048 | 0.779 |
MOD_GlcNHglycan | 213 | 216 | PF01048 | 0.557 |
MOD_GlcNHglycan | 28 | 31 | PF01048 | 0.543 |
MOD_GSK3_1 | 136 | 143 | PF00069 | 0.798 |
MOD_GSK3_1 | 146 | 153 | PF00069 | 0.559 |
MOD_GSK3_1 | 170 | 177 | PF00069 | 0.479 |
MOD_N-GLC_1 | 171 | 176 | PF02516 | 0.541 |
MOD_N-GLC_1 | 181 | 186 | PF02516 | 0.608 |
MOD_N-GLC_1 | 44 | 49 | PF02516 | 0.595 |
MOD_NEK2_1 | 181 | 186 | PF00069 | 0.606 |
MOD_NEK2_1 | 194 | 199 | PF00069 | 0.510 |
MOD_NEK2_1 | 204 | 209 | PF00069 | 0.503 |
MOD_NEK2_1 | 257 | 262 | PF00069 | 0.402 |
MOD_NEK2_1 | 268 | 273 | PF00069 | 0.280 |
MOD_PKA_2 | 170 | 176 | PF00069 | 0.609 |
MOD_Plk_1 | 171 | 177 | PF00069 | 0.472 |
MOD_Plk_1 | 44 | 50 | PF00069 | 0.598 |
MOD_Plk_2-3 | 93 | 99 | PF00069 | 0.629 |
MOD_Plk_4 | 204 | 210 | PF00069 | 0.469 |
MOD_Plk_4 | 257 | 263 | PF00069 | 0.214 |
TRG_DiLeu_BaEn_1 | 6 | 11 | PF01217 | 0.498 |
TRG_DiLeu_BaLyEn_6 | 248 | 253 | PF01217 | 0.513 |
TRG_ENDOCYTIC_2 | 231 | 234 | PF00928 | 0.683 |
TRG_ENDOCYTIC_2 | 53 | 56 | PF00928 | 0.618 |
TRG_ENDOCYTIC_2 | 8 | 11 | PF00928 | 0.495 |
TRG_ER_diArg_1 | 100 | 102 | PF00400 | 0.561 |
TRG_ER_diArg_1 | 11 | 13 | PF00400 | 0.551 |
TRG_ER_diArg_1 | 116 | 119 | PF00400 | 0.616 |
TRG_ER_diArg_1 | 18 | 21 | PF00400 | 0.635 |
TRG_ER_diArg_1 | 195 | 198 | PF00400 | 0.650 |
TRG_ER_diArg_1 | 276 | 279 | PF00400 | 0.495 |
TRG_ER_diArg_1 | 284 | 287 | PF00400 | 0.511 |
TRG_ER_diArg_1 | 34 | 37 | PF00400 | 0.700 |
TRG_ER_diArg_1 | 64 | 67 | PF00400 | 0.692 |
TRG_ER_diArg_1 | 68 | 71 | PF00400 | 0.682 |
TRG_Pf-PMV_PEXEL_1 | 101 | 105 | PF00026 | 0.459 |
TRG_Pf-PMV_PEXEL_1 | 119 | 123 | PF00026 | 0.618 |
TRG_Pf-PMV_PEXEL_1 | 21 | 25 | PF00026 | 0.486 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A3S5H5Z9 | Leishmania donovani | 88% | 100% |
A4H527 | Leishmania braziliensis | 67% | 100% |
A4HTA1 | Leishmania infantum | 88% | 100% |
Q4QIL4 | Leishmania major | 87% | 100% |
V5B888 | Trypanosoma cruzi | 26% | 78% |